Myricetin down-regulates phorbol ester-induced cyclooxygenase-2 expression in mouse epidermal cells by blocking activation of nuclear factor kappa B

Journal of Agricultural and Food Chemistry

Volumn 55, Issue 23, 2007, Pages 9678-9684

  Lee, Kyung Mi ^a   Nam, Joo Kang ^a   Jin, Hee Han ^b   Ki, Won Lee ^b   Hyong, Joo Lee ^a  

^a Seoul National University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Chemoprevention; Cyclooxygenase 2; Myricetin; Nuclear factor kappa B; Tumor promotion

Indexed keywords

CYCLOOXYGENASE 2; FLAVONOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYRICETIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL; ARTICLE; CELL LINE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; EPIDERMIS; GENETICS; MOUSE; WINE;

ANIMALS; CELL LINE; CYCLOOXYGENASE 2; DOWN-REGULATION; EPIDERMIS; FLAVONOIDS; MICE; NF-KAPPA B; TETRADECANOYLPHORBOL ACETATE; WINE;

EID: 36749032385     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf0717945     Document Type: Article

References (39)

1. Prescott, S. M.; Fitzpatrick, F. A. Cyclooxygenase-2 and carcinogenesis. Biochim. Biophys. Acta 2000, 1470, M69-78.
2. Dubois, R. N.; Abramson, S. B.; Crofford, L.; Gupta, R. A.; Simon, L. S.; Van De Putte, L. B.; Lipsky, P. E. Cyclooxygenase in biology and disease. FASEB J. 1998, 12, 1063-73.
3. Funk, C. D.; Funk, L. B.; Kennedy, M. E.; Pong, A. S.; Fitzgerald, G. A. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J. 1991, 5, 2304-12.
4. Gately, S. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev. 2000, 19, 19-27.
5. Ristimaki, A.; Sivula, A.; Lundin, J.; Lundin, M.; Salminen, T.; Haglund, C.; Joensuu, H.; Isola, J. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res. 2002, 62, 632-5.
6. Khuri, F. R.; Wu, H.; Lee, J. J.; Kemp, B. L.; Lotan, R.; Lippman, S. M.; Feng, L.; Hong, W. K.; Xu, X. C. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin. Cancer Res. 2001, 7, 861-7.
7. Turini, M. E.; DuBois, R. N. Cyclooxygenase-2: a therapeutic target. Annu. Rev. Med. 2002, 53, 35-57.
8. Zhang, X.; Chen, Z. G.; Choe, M. S.; Lin, Y.; Sun, S. Y.; Wieand, H. S.; Shin, H. J.; Chen, A.; Khuri, F. R.; Shin, D. M. Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model. Clin. Cancer Res. 2005, 11, 6261-9 .
9. Earnest, D. L.; Hixson, L. J.; Alberts, D. S. Piroxicam and other cyclooxygenase inhibitors: potential for cancer chemoprevention. J. Cell. Biochem. Suppl. 1992, 161, 156-66.
10. Aas, A. T.; Tonnessen, T. I.; Brun, A.; Salford, L. G. Growth inhibition of rat glioma cells in vitro and in vivo by aspirin. J. Neurooncol. 1995, 24, 171-80.
11. Chun, K. S.; Surh, Y. J. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem. Pharmacol. 2004, 68, 1089-100.
12. Surh, Y. J.; Chun, K. S.; Cha, H. H.; Han, S. S.; Keum, Y. S.; Park, K. K.; Lee, S. S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 2001, 480-481, 243-68.
13. Kundu, J. K.; Shin, Y. K.; Surh, Y. J. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets. Biochem. Pharmacol. 2006, 72, 1506-15.
14. Seve, M.; Chimienti, F.; Devergnas, S.; Aouffen, M.; Douki, T.; Chantegrel, J.; Cadet, J.; Favier, A. Resveratrol enhances UVA-induced DNA damage in HaCaT human keratinocytes. Med. Chem. 2005, 1, 629-33.
15. Heynekamp, J. J.; Weber, W. M.; Hunsaker, L. A.; Gonzales, A. M.; Orlando, R. A.; Deck, L. M.; Jagt, D. L. Substituted transstilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB. J. Med. Chem. 2006, 49, 7182-9.
16. Subbaramaiah, K.; Chung, W. J.; Michaluart, P.; Telang, N.; Tanabe, T.; Inoue, H.; Jang, M.; Pezzuto, J. M.; Dannenberg, A. J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 1998, 273, 21875-82.
17. Kundu, J. K.; Shin, Y. K.; Kim, S. H.; Surh, Y. J. Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity. Carcinogenesis 2006, 27, 1465-74.
18. Gosslau, A.; Chen, M.; Ho, C. T.; Chen, K. Y. A methoxy derivative of resveratrol analogue selectively induced activation of the mitochondrial apoptotic pathway in transformed fibroblasts. Br. J. Cancer 2005, 92, 513-21.
19. Ribeiro de Lima, M. T.; Waffo-Teguo, P.; Teissedre, P. L.; Pujolas, A.; Vercauteren, J.; Cabanis, J. C.; Merillon, J. M. Determination of stilbenes (trans-astringin, cis- and trans-piceid, and cis- and trans-resveratrol) in Portuguese wines. J. Agric. Food Chem. 1999, 47, 2666-70.
20. Waterhouse, A. L. Wine phenolics. Ann. NY. Acad. Sci. 2002, 957, 21-36.
21. Hertog, M. G.; Feskens, E. J.; Hollman, P. C.; Katan, M. B.; Kromhout, D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993, 342, 1007-11.
22. Noroozi, M.; Angerson, W. J.; Lean, M. E. Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. Am. J. Clin. Nutr. 1998, 67, 1210-8.
23. Mukhtar, H.; Das, M.; Khan, W. A.; Wang, Z. Y.; Bik, D. P.; Bickers, D. R. Exceptional activity of tannic acid among naturally occurring plant phenols in protecting against 7,12-dimethylbenz(a)anthracene-, benzo(a)pyrene-, 3-methylcholanthrene-, and N-methyl-N-nitrosourea-induced skin tumorigenesis in mice. Cancer Res. 1988, 48, 2361-5.
24. Chang, R. L.; Huang, M. T.; Wood, A. W.; Wong, C. Q.; Newmark, H. L.; Yagi, H.; Sayer, J. M.; Jerina, D. M.; Conney, A. H. Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo[a]pyrene and (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a] pyrene on mouse skin and in the newborn mouse. Carcinogenesis 1985, 6, 1127-33.
25. Das, M.; Khan, W. A.; Asokan, P.; Bickers, D. R.; Mukhtar, H. Inhibition of polycyclic aromatic hydrocarbon-DNA adduct formation in epidermis and lungs of SENCAR mice by naturally occurring plant phenols. Cancer Res. 1987, 47, 767-73.
26. Ko, C. H.; Shen, S. C.; Lee, T. J.; Chen, Y. C. Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Mol. Cancer Ther. 2005, 4, 281-90.
27. Lee, K. W.; Kim, Y. J.; Lee, H. J.; Lee, C. Y. Cocoa has more phenolic phytochemicals and a higher antioxidant capacity than teas and red wine. J. Agric. Food Chem. 2003, 51, 7292-7295.
28. Eberhart, C. E.; Coffey, R. J.; Radhika, A.; Giardiello, F. M.; Ferrenbach, S.; DuBois, R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994, 107, 1183-8.
29. Watanabe, O.; Shimizu, T.; Imamura, H.; Kinoshita, J.; Utada, Y.; Okabe, T.; Kimura, K.; Hirano, A.; Yoshimatsu, K.; Aiba, M.; Ogawa, K. Expression of cyclooxygenase-2 in malignant and benign breast tumors. Anticancer Res. 2003, 23, 3215-21.
30. Buckman, S. Y.; Gresham, A.; Hale, P.; Hruza, G.; Anast, J.; Masferrer, J.; Pentland, A. P. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 1998, 19, 723-9.
31. Athar, M.; An, K. P.; Morel, K. D.; Kim, A. L.; Aszterbaum, M.; Longley, J.; Epstein, E. H., Jr.; Bickers, D. R. Ultraviolet B(UVB)-induced cox-2 expression in murine skin: an immunohistochemical study. Biochem. Biophys. Res. Commun. 2001, 280, 1042-7.
32. Oshima, M.; Dinchuk, J. E.; Kargman, S. L.; Oshima, H.; Hancock, B.; Kwong, E.; Trzaskos, J. M.; Evans, J. F.; Taketo, M. M. Suppression of intestinal polyposis in Ape delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996, 87, 803-9.
33. Pentland, A. P.; Schoggins, J. W.; Scott, G. A.; Khan, K. N.; Han, R. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 1999, 20, 1939-44.
34. Wilgus, T. A.; Koki, A. T.; Zweifel, B. S.; Rubal, P. A.; Oberyszyn, T. M. Chemotherapeutic efficacy of topical celecoxib in a murine model of ultraviolet light B-induced skin cancer. Mol. Carcinog. 2003, 38, 33-9.
35. Min, S. Y.; Hwang, S. Y.; Jung, Y. O.; Jeong, J.; Park, S. H.; Cho, C. S.; Kim, H. Y.; Kim, W. U. Increase of cyclooxygenase-2 expression by interleukin 15 in rheumatoid synoviocytes. J. Rheumatol. 2004, 31, 875-83.
36. Nakao, S.; Ogtata, Y.; Shimizu, E.; Yamazaki, M.; Furuyama, S.; Sugiya, H. Tumor necrosis factor alpha (TNF-alpha)-induced prostaglandin E2 release is mediated by the activation of cyclooxygenase-2 (COX-2) transcription via NFkappaB in human gingival fibroblasts. Mol. Cell. Biochem. 2002, 238, 11-8.
37. Kim, Y.; Fischer, S. M. Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues. J. Biol. Chem. 1998, 273, 27686-94.
38. Chun, K. S.; Keum, Y. S.; Han, S. S.; Song, Y. S.; Kim, S. H.; Surh, Y. J. Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. Carcinogenesis 2003, 24, 1515-24.
39. German, J. B.; Walzem, R. L. The health benefits of wine. Annu. Rev. Nutr. 2000, 20, 561-93.